Suppr超能文献

半同种异体骨髓移植后急性移植物抗宿主病期间侵入皮肤的T细胞特异性

Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.

作者信息

Gaschet J, Mahé B, Milpied N, Devilder M C, Dréno B, Bignon J D, Davodeau F, Hallet M M, Bonneville M, Vié H

机构信息

Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.

出版信息

J Clin Invest. 1993 Jan;91(1):12-20. doi: 10.1172/JCI116160.

Abstract

The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after allogeneic bone marrow transplantation (BMT) are poorly understood. The exact role of various effector cell populations and "major" (particularly HLA-DP) or "minor" antigens as target molecules is not known. To investigate the nature of cells responsible for tissue injury, we cultured T cells from skin biopsy first with interleukin 2 (IL-2) alone and then in polyclonal activation conditions to avoid in vitro antigenic sensitization before specificity testing. We applied this method to two biopsies performed during aGVHD after semiallogeneic BMT and obtained cytotoxic T cells against four graft mismatches: CD8+ T cells against HLA-A2.2 and HLA-B27 and CD4+ T cells against HLA-DP101 and HLA-DP401. This demonstrates that T cells with documented specificity can be obtained from an aGVHD lesion without antigenic selection. Moreover, these data directly implicate DP as a potential target antigen for aGVHD.

摘要

异基因骨髓移植(BMT)后急性移植物抗宿主病(aGVHD)期间皮肤病变的发病机制尚不清楚。各种效应细胞群体以及作为靶分子的“主要”(特别是HLA - DP)或“次要”抗原的确切作用尚不清楚。为了研究造成组织损伤的细胞的性质,我们首先将皮肤活检获得的T细胞单独用白细胞介素2(IL - 2)培养,然后在多克隆激活条件下培养,以避免在特异性测试前进行体外抗原致敏。我们将这种方法应用于半同种异体BMT后aGVHD期间进行的两次活检,并获得了针对四种移植错配的细胞毒性T细胞:针对HLA - A2.2和HLA - B27的CD8 + T细胞以及针对HLA - DP101和HLA - DP401的CD4 + T细胞。这表明可以从aGVHD病变中获得具有明确特异性的T细胞而无需进行抗原选择。此外,这些数据直接表明DP是aGVHD的潜在靶抗原。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa6/329989/b796fc81e013/jcinvest00489-0031-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验